Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Table 2 A summary table for key studies and their conclusions
Ref. | Year | Study design | Findings | Limitations |
Wang et al[74] | 2024 | Cross-sectional study | HCV group without metabolic syndrome had higher odds ratio of 2.75 | While CT is a widely used method, it primarily detects advanced atherosclerosis (calcified plaques) and may miss earlier stages of the disease |
Chang et al[56] | 2022 | Population-based cohort | HCV patients have a high incidence of CVD, though it is lower than that of ALD and NAFLD | The findings may not be directly generalizable |
Petta et al[9] | 2011 | Case-control | Severe hepatic fibrosis is associated with a high risk of early carotid atherosclerosis in G1 CHC patients | Selection bias in the recruitment of the control population and limited generalizability |
Lee et al[72] | 2019 | Systematic review and meta-analysis | Patients with HCV had 28% higher risk compared to those without HCV infection | Limited generalizability on global scale, and significant heterogeneity |
Wen et al[75] | 2019 | Systematic review and meta-analysis | The overall RR of 1.25 in the cohort studies, higher OR of 1.94 in these studies suggests a stronger association between HCV and CAD compared to the cohort studies | Small sample size between studies and different criteria for diagnosing CHC |
Badawi et al[76] | 2018 | Survey analysis | HCV infection was significantly associated with a 25%-3.5% absolute risk increases of 10-year CVD after adjusting for sociodemographic and cardiometabolic risk factors | Confounding variables such as alcohol use, and drug use were not controlled |
Roed et al[65] | 2014 | Cross-sectional study | Higher carotid intima media thickness in CHC patients with small difference of means | Confounding variables such as physical activity, diet, medication use, family history of CAD, and genetic predisposition were not controlled |
- Citation: Elkhattib I, Raafat KW, Elsayed B, Elnaggar M. Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. World J Hepatol 2025; 17(8): 108678
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108678.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108678